Clinical Trial Update: Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department

View source ↗

Summary

A completed clinical trial evaluated procalcitonin as a diagnostic biomarker for bacterial infection in patients admitted with fever and/or systemic inflammator…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infection
• Systemic Inflammatory Response Syndrome

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Systemic Inflammatory Response Syndrome, Fever | Status: COMPLETED